Market Overview

Big Data in the Healthcare & Pharmaceutical Industry 2018-2030: Opportunities, Challenges, Strategies & Forecasts - ResearchAndMarkets.com

Share:

The "Big
Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 -
Opportunities, Challenges, Strategies & Forecasts"
report
from SNS Telecom & IT has been added to ResearchAndMarkets.com's
offering.

Amid the proliferation of real-time and historical data from sources
such as connected devices, web, social media, sensors, log files and
transactional applications, Big Data is rapidly gaining traction from a
diverse range of vertical sectors. The healthcare and pharmaceutical
industry is no exception to this trend, where Big Data has found a host
of applications ranging from drug discovery and precision medicine to
clinical decision support and population health management.

This research estimates that Big Data investments in the healthcare and
pharmaceutical industry will account for nearly $4.7 Billion in 2018
alone. Led by a plethora of business opportunities for healthcare
providers, insurers, payers, government agencies, pharmaceutical
companies and other stakeholders, these investments are further expected
to grow at a CAGR of approximately 12% over the next three years.

The report presents an in-depth assessment of Big Data in the healthcare
and pharmaceutical industry including key market drivers, challenges,
investment potential, application areas, use cases, future roadmap,
value chain, case studies, vendor profiles and strategies.

The report also presents market size forecasts for Big Data hardware,
software and professional services investments from 2018 through to
2030. The forecasts are segmented for 8 horizontal submarkets, 5
application areas, 37 use cases, 6 regions and 35 countries.

Key Findings:

  • In 2018, Big Data vendors will pocket nearly $4.7 Billion from
    hardware, software and professional services revenues in the
    healthcare and pharmaceutical industry. These investments are further
    expected to grow at a CAGR of approximately 12% over the next three
    years, eventually accounting for more than $7 Billion by the end of
    2021.
  • Big Data and advanced analytics are driving a paradigm shift in the
    healthcare and pharmaceutical industry with multiple innovations
    ranging from precision medicine and digital therapeutics to the
    adoption of accountable and value-based care models.
  • Drug developers are making substantial investments in Big Data and
    artificial intelligence-driven drug discovery platforms to shorten the
    process of successfully discovering promising compounds. In addition,
    Big Data technologies are increasingly being utilized to streamline
    clinical trials, enabling biopharmaceutical companies to significantly
    lower costs and accelerate productive trials.
  • The growing adoption of Big Data technologies has also brought about
    an array of benefits for hospitals and other healthcare facilities.
    Based on feedback from healthcare providers worldwide, these include
    but are not limited to cost savings in the range of 20-30%, an
    increase in patient access to services by more than 35%, growth in
    revenue by up to 30%, a reduction in emergency room visits by 10%, a
    drop in patient wait times by 30-60%, improvements in outcomes by as
    much as 20%, a 10-50% decline in mortality rates for conditions such
    as heart failure, and a reduction in the occurrence of hospital
    acquired and surgical site infections by nearly 60%.

Key Topics Covered

Chapter 1: Introduction

Chapter 2: An Overview of Big Data

Chapter 3: Big Data Analytics

Chapter 4: Business Case & Applications in the Healthcare &
Pharmaceutical Industry

Chapter 5: Healthcare & Pharmaceutical Industry Case Studies

Chapter 6: Future Roadmap & Value Chain

Chapter 7: Standardization & Regulatory Initiatives

Chapter 8: Market Sizing & Forecasts

Chapter 9: Vendor Landscape

Chapter 10: Conclusion & Strategic Recommendations

Companies Featured

  • 1010data
  • AbbVie
  • Absolutdata
  • Accenture
  • AVORA
  • AWS (Amazon Web Services)
  • Axiomatics
  • BackOffice Associates
  • Bangkok Hospital Group
  • Basho Technologies
  • Bayer
  • BlueTalon
  • BMC Software
  • BMS (Bristol-Myers Squibb)
  • BOARD International
  • Centrifuge Systems
  • CenturyLink
  • Chartio
  • Cigna
  • Cisco Systems
  • Demandbase
  • Denodo Technologies
  • Erwin
  • EXASOL
  • Express Scripts
  • Exscientia
  • Facebook
  • Faros Healthcare
  • GE (General Electric)
  • Genomics England
  • Yseop
  • Zendesk
  • Zoomdata
  • Zucchetti
  • and many, many more...

For more information about this report visit https://www.researchandmarkets.com/research/56n8t2/big_data_in_the?w=4

View Comments and Join the Discussion!